Posted by Michael Wonder on 30 Jun 2022
Schedule of Pharmaceutical Benefits - 1 July 2022
1 July 2022 - The July 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The July issue of the Schedule includes a few new/revised listings:
- Amifampridine (Ruzurgi) - new medicine
- Larotrectinib sulphate (Vitrakvi) - new medicine
- Zanubrutinib (Brukinsa) - new indication
